Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

NCT00062621

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

NCT00002652

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Completed

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

NCT00007995

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States

View Trial Details

Completed

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

NCT00003451

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

FR901228 in Treating Patients With Hematologic Cancer

NCT00024180

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder

NCT00064246

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +32 more
Locations: AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States

View Trial Details

Completed

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Bortezomib-Dexamethasone-Doxorubicin-Study

NCT00401804

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +20 more
Locations: Landeskrankenhaus Feldkirch Feldkirch, Austria

Klinischen Abteilung für Hämatologie, Medizinische Universitätsklinik Graz Graz, Austria

Landeskrankenhaus Leoben Leoben, Austria

Dep. of Internal Medicine I, Oncology, SALK - Gemeinnützige Salzburger Landeskliniken Salzburg, Austria

View Trial Details

Completed

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

NCT00098891

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +92 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions